Chun Deng

1.1k total citations
20 papers, 804 citations indexed

About

Chun Deng is a scholar working on Molecular Biology, Oncology and Genetics. According to data from OpenAlex, Chun Deng has authored 20 papers receiving a total of 804 indexed citations (citations by other indexed papers that have themselves been cited), including 10 papers in Molecular Biology, 6 papers in Oncology and 4 papers in Genetics. Recurrent topics in Chun Deng's work include Epigenetics and DNA Methylation (5 papers), Immune Cell Function and Interaction (3 papers) and HER2/EGFR in Cancer Research (3 papers). Chun Deng is often cited by papers focused on Epigenetics and DNA Methylation (5 papers), Immune Cell Function and Interaction (3 papers) and HER2/EGFR in Cancer Research (3 papers). Chun Deng collaborates with scholars based in China, United States and United Kingdom. Chun Deng's co-authors include Bruce Richardson, Zhiyong Zhang, Qianjin Lu, Samir Hanash, Raymond Yung, T. Dharma Rao, Qianjin Lu, Jun Yang, Bruce C. Richardson and Chunbao Guo and has published in prestigious journals such as Proceedings of the National Academy of Sciences, The Journal of Immunology and Cancer Research.

In The Last Decade

Chun Deng

20 papers receiving 786 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Chun Deng China 12 454 269 127 123 112 20 804
Ulrika Liljedahl Sweden 14 329 0.7× 147 0.5× 143 1.1× 124 1.0× 122 1.1× 21 765
Prince George United States 6 945 2.1× 162 0.6× 98 0.8× 34 0.3× 142 1.3× 9 1.2k
Jürgen Steffgen Germany 14 228 0.5× 146 0.5× 57 0.4× 83 0.7× 145 1.3× 25 639
Rocky Pramanik United States 14 292 0.6× 143 0.5× 71 0.6× 42 0.3× 170 1.5× 18 613
Yao Fu United States 12 740 1.6× 109 0.4× 317 2.5× 108 0.9× 79 0.7× 26 1.0k
Gregory C. Spies United States 2 344 0.8× 75 0.3× 70 0.6× 31 0.3× 77 0.7× 2 552
Magdalene K. Sgagias United States 11 361 0.8× 130 0.5× 128 1.0× 118 1.0× 395 3.5× 14 760
John Dulos Netherlands 14 196 0.4× 259 1.0× 83 0.7× 63 0.5× 300 2.7× 22 673
Jolanta Kosek United States 9 528 1.2× 140 0.5× 196 1.5× 70 0.6× 160 1.4× 15 830
Irina V. Bure Russia 13 411 0.9× 59 0.2× 62 0.5× 98 0.8× 121 1.1× 42 697

Countries citing papers authored by Chun Deng

Since Specialization
Citations

This map shows the geographic impact of Chun Deng's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Chun Deng with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Chun Deng more than expected).

Fields of papers citing papers by Chun Deng

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Chun Deng. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Chun Deng. The network helps show where Chun Deng may publish in the future.

Co-authorship network of co-authors of Chun Deng

This figure shows the co-authorship network connecting the top 25 collaborators of Chun Deng. A scholar is included among the top collaborators of Chun Deng based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Chun Deng. Chun Deng is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Lian, Wei, et al.. (2025). Abstract 2940: Preclinical development of a next generation antibody drug conjugate (ADC) targeting CDH17 for treatment of solid tumors. Cancer Research. 85(8_Supplement_1). 2940–2940. 1 indexed citations
2.
Xue, Tongtong, et al.. (2025). Abstract 3140: Preclinical development of YL242, a non-internalized antibody-drug conjugate (ADC) targeting soluble VEGF for treatment of solid tumors. Cancer Research. 85(8_Supplement_1). 3140–3140. 1 indexed citations
3.
4.
Li, Weiwei, Ting Lei, Xiaoyu Song, et al.. (2022). CBLC inhibits the proliferation and metastasis of breast cancer cells via ubiquitination and degradation of CTTN. Journal of Receptors and Signal Transduction. 42(6). 588–598. 3 indexed citations
5.
6.
Xiao, Bin, Zhenzhan Kuang, Weiyun Zhang, et al.. (2019). Glutamate Ionotropic Receptor Kainate Type Subunit 3 (GRIK3) promotes epithelial‐mesenchymal transition in breast cancer cells by regulating SPDEF/CDH1 signaling. Molecular Carcinogenesis. 58(7). 1314–1323. 23 indexed citations
7.
Guo, Chunbao, et al.. (2014). Aberrant elastin remodeling in the lungs of O2-exposed newborn mice; primarily results from perturbed interaction between integrins and elastin. Cell and Tissue Research. 359(2). 589–603. 23 indexed citations
8.
Guo, Chunbao, et al.. (2009). [Retrospective analysis of maternal and infant birth features of hepatoblastoma patients].. PubMed. 17(6). 459–61. 11 indexed citations
9.
Jin, Xianqing, Ziming Wang, Dianliang Zhang, et al.. (2008). Potential biomarkers involving IKK/RelA signal in early stage non‐small cell lung cancer. Cancer Science. 99(3). 582–589. 39 indexed citations
10.
Ashwell, Susan, Benjamin Caleb, Chun Deng, et al.. (2007). Preclinical identification of AZD7762, a novel, potent and selective inhibitor of Checkpoint kinases. Molecular Cancer Therapeutics. 6. 3 indexed citations
11.
Deng, Chun, et al.. (2007). Three mutations analysis of glucose‐6‐phosphate dehydrogenase deficiency in neonates in South‐west China. Pediatrics International. 49(4). 463–467. 5 indexed citations
12.
Guo, Chunbao, Shan Wang, Chun Deng, et al.. (2007). Relationship between Matrix Metalloproteinase 2 and Lung Cancer Progression. Molecular Diagnosis & Therapy. 11(3). 183–192. 57 indexed citations
13.
Lyne, Paul D., Peter W. Kenny, David A. Cosgrove, et al.. (2004). Identification of Compounds with Nanomolar Binding Affinity for Checkpoint Kinase-1 Using Knowledge-Based Virtual Screening. Journal of Medicinal Chemistry. 47(8). 1962–1968. 71 indexed citations
14.
Lu, Qianjin, Ailing Wu, Donna Ray, et al.. (2003). DNA Methylation and Chromatin Structure Regulate T Cell Perforin Gene Expression. The Journal of Immunology. 170(10). 5124–5132. 102 indexed citations
15.
Deng, Chun, Qianjin Lu, Zhiyong Zhang, et al.. (2003). Hydralazine may induce autoimmunity by inhibiting extracellular signal–regulated kinase pathway signaling. Arthritis & Rheumatism. 48(3). 746–756. 207 indexed citations
16.
Zhang, Zhiyong, Chun Deng, Qianjin Lu, & Bruce Richardson. (2002). Age-dependent DNA methylation changes in the ITGAL (CD11a) promoter. Mechanisms of Ageing and Development. 123(9). 1257–1268. 94 indexed citations
17.
Yung, Raymond, David Ray, Chun Deng, et al.. (2001). Unexpected Effects of a Heterozygous Dnmt1 Null Mutation on Age-Dependent DNA Hypomethylation and Autoimmunity. The Journals of Gerontology Series A. 56(6). B268–B276. 35 indexed citations
18.
Zhu, Xiaoxiang, Chun Deng, Rork Kuick, et al.. (1999). Analysis of human peripheral blood T cells and single-cell-derived T cell clones uncovers extensive clonal CpG island methylation heterogeneity throughout the genome. Proceedings of the National Academy of Sciences. 96(14). 8058–8063. 25 indexed citations
19.
Deng, Chun, Jun Yang, Jeannine M. Scott, Samir Hanash, & Bruce C. Richardson. (1998). Role of the ras-MAPK Signaling Pathway in the DNA Methyltransferase Response to DNA Hypomethylation. Biological Chemistry. 379(8-9). 1113–1120. 61 indexed citations
20.
Yang, Jun, Chun Deng, Nahid Hemati, Samir Hanash, & Bruce C. Richardson. (1997). Effect of mitogenic stimulation and DNA methylation on human T cell DNA methyltransferase expression and activity. The Journal of Immunology. 159(3). 1303–1309. 38 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Ulrika Liljedahl Breakdown of academic impact, for papers by Prince George Breakdown of academic impact, for papers by Jürgen Steffgen Breakdown of academic impact, for papers by Rocky Pramanik Breakdown of academic impact, for papers by Yao Fu Breakdown of academic impact, for papers by Gregory C. Spies Breakdown of academic impact, for papers by Magdalene K. Sgagias Breakdown of academic impact, for papers by John Dulos Breakdown of academic impact, for papers by Jolanta Kosek Breakdown of academic impact, for papers by Irina V. Bure
Rankless by CCL
2026